Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED
02 1Teva API India Private Limited
03 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
04 1Arch Pharmalabs Limited
05 2Biocon Limited
06 1Cadila Pharmaceuticals Limited
07 1Changzhou Pharmaceutical Factory
08 1Chromo Laboratories India Private Limited
09 1Hetero Drugs Limited
10 1Hetero Labs Limited
11 1Jubilant Pharmova Limited
12 1MSN Life Sciences Private Limited
13 3MSN Pharmachem Private Limited
14 1MYLAN LABORATORIES LIMITED
15 1Novartis Pharmaceuticals Corporation
16 1PURE AND CURE HEALTHCARE PRIVATE LIMITED
17 1Professional Compounding Centers of America dba PCCA
18 2Tianish Laboratories Private Limited
19 1Upjohn Manufacturing Ireland Unlimited Company
20 1Willow Birch Pharma, Inc
21 1ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.
22 1Zhejiang Jiangbei Pharmaceutical Co., Ltd.
01 5ATORVASTATIN CALCIUM
02 2ATORVASTATIN CALCIUM TRIHYDRATE
03 1Atorvastatin
04 8Atorvastatin Calcium
05 1Atorvastatin Calcium Amorphous
06 1Atorvastatin Calcium Form-I
07 2Atorvastatin Calcium Trihydrate
08 1Atorvastatin calcium
09 1Atorvastatin calcium crystalline
10 1Atorvastatin calcium trihydrate
11 1atorvastatin
12 1atorvastatin calcium
13 1atorvastatin calcium amorphous
01 3China
02 15India
03 1Israel
04 1Netherlands
05 1Switzerland
06 3U.S.A
07 1United Kingdom
08 1Blank
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 70269-300
Start Marketing Date : 2015-08-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 15894-0023
Start Marketing Date : 2013-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 22365-004
Start Marketing Date : 2009-01-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM ANHYDROUS
NDC Package Code : 50370-0046
Start Marketing Date : 2009-07-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 50370-0017
Start Marketing Date : 2010-04-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM ANHYDROUS
NDC Package Code : 50370-0018
Start Marketing Date : 2010-04-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 0078-1371
Start Marketing Date : 2013-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 51927-5153
Start Marketing Date : 2021-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 10695-166
Start Marketing Date : 2024-05-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ATORVASTATIN CALCIUM TRIHYDRATE
NDC Package Code : 13403-215
Start Marketing Date : 2024-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
12
PharmaCompass offers a list of Atorvastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atorvastatin manufacturer or Atorvastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atorvastatin manufacturer or Atorvastatin supplier.
PharmaCompass also assists you with knowing the Atorvastatin API Price utilized in the formulation of products. Atorvastatin API Price is not always fixed or binding as the Atorvastatin Price is obtained through a variety of data sources. The Atorvastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atorvastatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atorvastatin, including repackagers and relabelers. The FDA regulates Atorvastatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atorvastatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atorvastatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atorvastatin supplier is an individual or a company that provides Atorvastatin active pharmaceutical ingredient (API) or Atorvastatin finished formulations upon request. The Atorvastatin suppliers may include Atorvastatin API manufacturers, exporters, distributors and traders.
click here to find a list of Atorvastatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atorvastatin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atorvastatin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atorvastatin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atorvastatin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atorvastatin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atorvastatin suppliers with NDC on PharmaCompass.
We have 19 companies offering Atorvastatin
Get in contact with the supplier of your choice:
